Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion type Assertion NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_head.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion description "[None of the SNPs on these loci independently could modify the risk of the diseases in overall population but variant genotype (Gln/Gln) at codon 399 on XRCC1 and major genotype (Lys/Lys) at codon 751 on XPD were associated with increased risk of leukoplakia and cancer among slow acetylators, respectively (OR = 4.2, 95% CI = 1.2-15.0; OR = 1.6, 95% CI = 1.1-2.3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_provenance.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion evidence source_evidence_literature NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_provenance.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion SIO_000772 17290401 NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_provenance.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion wasDerivedFrom befree-20140225 NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_provenance.
- NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_assertion wasGeneratedBy ECO_0000203 NP452314.RA11Qd6djrJzMYsE5a7IGlwVHUWVol2N2qstZO3WQiKdk130_provenance.